Clinical Trials Directory

Trials / Unknown

UnknownNCT06194760

Evaluation of Vitrectomy With ILM Peeling in Myopic Macular Hole With Only Posterior Retinal Detachment

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
15 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Retinal detachment (RD) resulting from the macular hole (MH), also known as MH-induced RD (MHRD), most commonly occurs in eyes with high myopia and results in irreversible visual disorders. Although ILM peeling for MHRD reportedly achieves a high retinal reattachment rate that ranges from 70% to 100%, the MH closure rate is relatively low, ranging from 10% to 70%.

Conditions

Interventions

TypeNameDescription
PROCEDUREVitrectomy with ILM peelingVitrectomy with traditional internal limiting membrane (ILM) peeling technique is regarded as the gold standard treatment for MH; it works by completely relieving of the traction of the macula and increasing the flexibility of the retina

Timeline

Start date
2022-01-01
Primary completion
2023-12-01
Completion
2024-01-15
First posted
2024-01-08
Last updated
2024-01-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06194760. Inclusion in this directory is not an endorsement.